Gene · 4014
Papers2,126
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,126
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Chitosan-based drug delivery systems for skin atopic dermatitis: recent advancements and patent trends. | Drug Deliv Transl Res | 2023 | 36808298 | PubTator, text mining | PubMed |
| Transglutaminase Activity Is Conserved in Stratified Epithelia and Skin Appendages of Mammals and Birds. | Int J Mol Sci | 2023 | 36768511 | PubTator, text mining | PubMed |
| Increased Serum Levels of Tumor Necrosis Factor-like Ligand 1A in Atopic Dermatitis. | Int J Mol Sci | 2023 | 36768135 | PubTator, text mining | PubMed |
| Single-cell analysis reveals melanocytes may promote inflammation in chronic wounds through cathepsin G. | Front Genet | 2023 | 36755572 | PubTator, text mining | PubMed |
| Low dose TGF-β1 can improve vohwinkel syndrome by promoting the proliferation of keratinocytes. | Acta Histochem | 2023 | 36738515 | PubTator, text mining | PubMed |
| Protective effect of Saussurea involucrata polysaccharide against skin dryness induced by ultraviolet radiation. | Front Pharmacol | 2023 | 36733502 | PubTator, text mining | PubMed |
| Differential cell composition and split epidermal differentiation in human palm, sole, and hip skin. | Cell Rep | 2023 | 36732947 | PubTator, text mining | PubMed |
| Induction of psoriasis- and atopic dermatitis-like phenotypes in 3D skin equivalents with a fibroblast-derived matrix. | Sci Rep | 2023 | 36720910 | PubTator, text mining | PubMed |
| Engineering edgeless human skin with enhanced biomechanical properties. | Sci Adv | 2023 | 36706190 | PubTator, text mining | PubMed |
| Shedding light on key pharmacological knowledge and strategies for pediatric atopic dermatitis. | Expert Rev Clin Pharmacol | 2023 | 36705936 | PubTator, text mining | PubMed |
| CARD14 Missense Variant Underlying CARD14-Associated Papulosquamous Eruption with Beneficial Response to Secukinumab. | JID Innov | 2023 | 36699196 | PubTator, text mining | PubMed |
| Alleviation of imiquimod-induced psoriasis-like symptoms in Rorα-deficient mouse skin. | BMB Rep | 2023 | 36698281 | PubTator, text mining | PubMed |
| Screening cell-cell communication in spatial transcriptomics via collective optimal transport. | Nat Methods | 2023 | 36690742 | PubTator, text mining | PubMed |
| The Staphylococcus aureus protein IsdA increases SARS CoV-2 replication by modulating JAK-STAT signaling. | iScience | 2023 | 36687318 | PubTator, text mining | PubMed |
| A Novel Perilla frutescens (L.) Britton Cell-Derived Phytocomplex Regulates Keratinocytes Inflammatory Cascade and Barrier Function and Preserves Vaginal Mucosal Integrity In Vivo. | Pharmaceutics | 2023 | 36678869 | PubTator, text mining | PubMed |
| Severe Burn Injury Significantly Alters the Gene Expression and m6A Methylation Tagging of mRNAs and lncRNAs in Human Skin. | J Pers Med | 2023 | 36675811 | PubTator, text mining | PubMed |
| New Data on the Features of Skin Barrier in Hidradenitis Suppurativa. | Biomedicines | 2023 | 36672635 | PubTator, text mining | PubMed |
| SIRT5 reduces the inflammatory response and barrier dysfunction in IL-17A-induced epidermal keratinocytes. | Allergol Immunopathol (Madr) | 2023 | 36617819 | PubTator, text mining | PubMed |
| Immunopathogenesis of Atopic Dermatitis: Focus on Interleukins as Disease Drivers and Therapeutic Targets for Novel Treatments. | Int J Mol Sci | 2023 | 36614224 | PubTator, text mining | PubMed |
| Morus alba fruits attenuates atopic dermatitis symptoms and pathology in vivo and in vitro via the regulation of barrier function, immune response and pruritus. | Phytomedicine | 2023 | 36610150 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4014/papers?page=18